-
Posted by
Two Blokes Jun 17 -
Filed in
Stock
-
4 views
BEIJING--(BUSINESS WIRE)--The Board of Directors of SINOVAC Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced several important decisions to deliver sustainable value to shareholders and strengthen the Company's governance framework. Currently, a dissenting investor group led by Advantech/Prime Success and Vivo Capital (together known as the “Dissenting Investor Group”) and certain former illegitimate board (the “.
